These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8328236

  • 1. Carcinoma of ovarian and other origins in effusions. Immunocytochemical study with a panel of monoclonal antibodies.
    Flynn MK, Johnston W, Bigner S.
    Acta Cytol; 1993; 37(4):439-47. PubMed ID: 8328236
    [Abstract] [Full Text] [Related]

  • 2. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
    Cuijpers VM, Boerman OC, Salet van de Pol MR, Vooijs GP, Poels LG, Ramaekers FC.
    Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129
    [Abstract] [Full Text] [Related]

  • 3. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B, Berner A, Nesland JM, Risberg B, Kristensen GB, Tropé CG, Bryne M.
    Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
    [Abstract] [Full Text] [Related]

  • 4. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions.
    Szpak CA, Johnston WW, Lottich SC, Kufe D, Thor A, Schlom J.
    Acta Cytol; 1984 Sep; 28(4):356-67. PubMed ID: 6205527
    [Abstract] [Full Text] [Related]

  • 5. Distinction between carcinoma cells and mesothelial cells in serous effusions. Usefulness of immunohistochemistry.
    Tickman RJ, Cohen C, Varma VA, Fekete PS, DeRose PB.
    Acta Cytol; 1990 Sep; 34(4):491-6. PubMed ID: 2197840
    [Abstract] [Full Text] [Related]

  • 6. [Cell-block immunocytochemical characterization of effusions. Use of antibody panel: calretinin, Ber-EP4, keratin and CD68].
    Lucchi I, Morigi F, Naldi S, Tabarri B, Elegibili E, Giangaspero F.
    Pathologica; 1999 Dec; 91(6):447-52. PubMed ID: 10783640
    [Abstract] [Full Text] [Related]

  • 7. Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases.
    Davidson B, Dong HP, Berner A, Christensen J, Nielsen S, Johansen P, Bryne M, Asschenfeldt P, Risberg B.
    Am J Clin Pathol; 2002 Jul; 118(1):85-92. PubMed ID: 12109861
    [Abstract] [Full Text] [Related]

  • 8. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
    Comin CE, Saieva C, Messerini L.
    Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
    [Abstract] [Full Text] [Related]

  • 9. Immunocytochemical staining of smears and corresponding cell blocks from serous effusions: a follow-up and comparative investigation.
    Jensen ML, Johansen P.
    Diagn Cytopathol; 1996 Jul; 15(1):33-6. PubMed ID: 8807249
    [Abstract] [Full Text] [Related]

  • 10. The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions.
    Davidson B, Dong HP, Holth A, Berner A, Risberg B.
    Breast J; 2008 Jul; 14(5):476-82. PubMed ID: 18657145
    [Abstract] [Full Text] [Related]

  • 11. Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3.
    Thor A, Gorstein F, Ohuchi N, Szpak CA, Johnston WW, Schlom J.
    J Natl Cancer Inst; 1986 Jun; 76(6):995-1006. PubMed ID: 3520078
    [Abstract] [Full Text] [Related]

  • 12. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
    Bassarova AV, Nesland JM, Davidson B.
    Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of epithelial ovarian neoplasm immunologic reactivity using monoclonal antibodies].
    Bar J, Sobańska E.
    Ginekol Pol; 1994 Sep; 65(9):502-7. PubMed ID: 7721163
    [Abstract] [Full Text] [Related]

  • 14. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
    Davidson B, Berner A, Nesland JM, Risberg B, Berner HS, Tropè CG, Kristensen GB, Bryne M, Ann Florenes V.
    J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
    [Abstract] [Full Text] [Related]

  • 15. Monoclonal antibodies against ovarian carcinoma-associated antigens, raised by immunization with cyst fluids.
    Boerman O, Makkink K, Massuger L, Thomas C, Kenemans P, Hanselaar T, Poels L.
    Anticancer Res; 1989 Dec; 9(3):551-8. PubMed ID: 2764501
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
    Ciampa A, Fanger G, Khan A, Rock KL, Xu B.
    Cancer; 2004 Dec 25; 102(6):368-72. PubMed ID: 15558786
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
    Esheba GE, Pate LL, Longacre TA.
    Am J Surg Pathol; 2008 Apr 25; 32(4):600-7. PubMed ID: 18277882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.